Delivery Order SPE2DR25D1202-SPE2DR26F73GF
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,936.96 delivery order on July 23, 2025, for XYOSTED 75 mg/0.5 mL auto-injector units (0.5 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,860.27 to AmerisourceBergen Drug Corp for the supply of XYOSTED 75 mg/0.5 mL auto-injector units, a testosterone replacement therapy medication. This competitively awarded, firm fixed-price delivery order was issued on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of XYOSTED 75 mg/0.5 ml auto-injector vials valued at $1,350.39 with completion targeted for October 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,044.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units, with an ultimate completion date of November 6, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. Performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector supplies valued at $5,675.20 on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed price delivery order represents AmerisourceBergen's continued role as a critical pharmaceutical supplier to federal medical procurement needs. The contract is not set-aside and performs out of the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $2,366.55 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies on October 31, 2025, with completion targeted for November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,430.40 to AmerisourceBergen Drug Corp for the supply of XYOSTED 75 mg/0.5 mL auto-injector units. This non-set-aside, firm fixed-price delivery order was awarded on December 1, 2025, with a completion date of December 2, 2025, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The product is a testosterone replacement therapy medication supplied in pre-filled auto-injector format, reflecting the...
- The Defense Logistics Agency awarded a $2,401.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies on December 2, 2025, with completion scheduled for December 3, 2025. This competitively awarded, non-set-aside order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector units valued at $1,094.38 with a firm fixed price structure. This non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate completion date for this delivery...
- The Defense Logistics Agency awarded a $1,183.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of December 4, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...